Related Experiment Videos
Systemic candidiasis with acute Epstein-Barr virus infection
M Hacimustafaoglu1, B Ener, O Tarim
1Department of Paediatrics, Uludag University Medical Faculty, Bursa, Turkey.
Acta Paediatrica (Oslo, Norway : 1992)
|December 24, 1997
Summary
Invasive Candida infections, typically seen in immunocompromised individuals, were unexpectedly diagnosed in two previously healthy children. Both children also had Epstein-Barr virus infection and were successfully treated with fluconazole.
Area of Science:
- Infectious Diseases
- Pediatrics
- Mycology
Background:
- Systemic Candida infections are opportunistic, primarily affecting immunocompromised individuals.
- Invasive non-albicans Candida infections are rare in healthy children.
- Epstein-Barr virus (EBV) infection typically does not cause clinically significant immunosuppression.
Observation:
- Two previously healthy male children, aged 2 and 9 years, presented with invasive Candida infections.
- One child had sepsis due to Candida species, while the other experienced sepsis and arthritis due to Candida parapsilosis.
- Both children had concurrent acute Epstein-Barr virus infection, confirmed serologically.
Findings:
- This report details the first known cases of invasive non-albicans Candida infection complicating Epstein-Barr virus infection in previously healthy children.
- Diagnosis was confirmed via blood cultures for Candida species.
- Both patients achieved a complete cure following antifungal treatment with fluconazole.
Implications:
- These cases suggest a potential, previously unreported association between Epstein-Barr virus infection and invasive Candida infections in pediatric populations.
- Highlights the importance of considering invasive fungal infections even in seemingly healthy children presenting with sepsis or arthritis, especially if concurrent viral infections are present.
- Further research is warranted to elucidate the potential mechanisms linking EBV infection and invasive candidiasis in children.